NDC 23155-748-31 - pentamidine isethionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23155-748
- Requested NDC
- 23155-748-31
- Package NDCs from labels
- 23155-748-31, 23155-748-41
- Manufacturer
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | Immacule Lifesciences Private Limited
- Effective date
- 2025-10-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| For Injection Only | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | Immacule Lifesciences Private Limited | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23155-748-31 | pentamidine isethionate | 300 mg in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 300 | 7 | |
| 23155-748-41 | pentamidine isethionate | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 23155-748 | PENTAMIDINE ISETHIONATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] | 6 | Current NDC, Legacy NDC, 2 package rows | 20231102_5c14fbf2-e21f-44b3-b35c-06919d40d7e0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-748-31 | EA - Each | 23155-748 | 31c31ab1-9b40-4531-b09d-28f2c72cb784 | 1 | 2021-06-02 |
| 23155-748-41 | EA - Each | 23155-748 | 17bed1e9-8809-4cb4-b705-c8205d049965 | 1 | 2021-06-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | PAI Holdings, LLC dba PAI Pharma | 4c01d8e9-a25b-4046-8924-53bd9acd560d | 2026-06-12 | Warnings, Adverse reactions | V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | PAI Holdings, LLC dba PAI Pharma | d46aea4f-8f3f-4ce0-93d6-94e147f5a31a | 2026-05-07 | Warnings, Adverse reactions | 861601 V2P3K60DA2 |
| pentamidine isethionate | PENTAMIDINE ISETHIONATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 5c14fbf2-e21f-44b3-b35c-06919d40d7e0 | 2025-10-31 | Warnings, Adverse reactions | ANDA213806 23155-748-31 23155-748-41 23155-748 23155074831 861601 77269af7-78f2-4f7d-bfe9-bdcd2bedaa86 5c14fbf2-e21f-44b3-b35c-06919d40d7e0 V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | Seton Pharmaceuticals | c484f16e-9d97-4416-84a4-8ad8deaf5e19 | 2025-04-08 | Warnings, Adverse reactions | V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | Seton Pharmaceuticals | cb8e8155-5505-44d5-9dee-525e2e45b95d | 2025-04-02 | Warnings, Adverse reactions | 861601 V2P3K60DA2 |
| NebuPent | PENTAMIDINE ISETHIONATE | Fresenius Kabi USA, LLC | e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb | 2024-10-15 | Warnings, Adverse reactions | V2P3K60DA2 |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | XGen Pharmaceuticals DJB, Inc. | 490a231d-bb24-403d-9733-1a562ecd5917 | 2024-03-18 | Warnings, Adverse reactions | V2P3K60DA2 |
| PENTAMIDINE ISETHIONATE | PENTAMIDINE ISETHIONATE | XGen Pharmaceuticals DJB, Inc. | 860c799c-5199-4f0c-b21b-9910273474d9 | 2024-01-25 | Warnings, Adverse reactions | 861601 V2P3K60DA2 |
| Pentam 300 | PENTAMIDINE ISETHIONATE | Fresenius Kabi USA, LLC | cc2b635e-4840-4dc3-a177-5484371680e8 | 2022-09-13 | Warnings, Adverse reactions | 861601 V2P3K60DA2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.